$0.83
4.33% yesterday
NYSE, Jun 11, 10:04 pm CET
ISIN
US44916K1060
Symbol
HYPR

Hyperfine Stock price

$0.83
+0.10 14.23% 1M
-0.16 16.19% 6M
-0.05 5.24% YTD
-0.06 7.03% 1Y
-9.18 91.67% 5Y
-9.18 91.67% 10Y
-9.18 91.67% 20Y
NYSE, Closing price Wed, Jun 11 2025
+0.03 4.33%
ISIN
US44916K1060
Symbol
HYPR
Sector

Key metrics

Market capitalization $64.91m
Enterprise Value $31.82m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.71
P/S ratio (TTM) P/S ratio 5.53
P/B ratio (TTM) P/B ratio 1.51
Revenue growth (TTM) Revenue growth 0.34%
Revenue (TTM) Revenue $11.73m
EBIT (operating result TTM) EBIT $-43.48m
Free Cash Flow (TTM) Free Cash Flow $-36.22m
Cash position $33.09m
EPS (TTM) EPS $-0.55
P/E forward negative
P/S forward 4.53
EV/Sales forward 2.22
Short interest 1.97%
Show more

Is Hyperfine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Hyperfine Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Hyperfine forecast:

2x Buy
50%
2x Hold
50%

Analyst Opinions

4 Analysts have issued a Hyperfine forecast:

Buy
50%
Hold
50%

Financial data from Hyperfine

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12 12
0% 0%
100%
- Direct Costs 6.31 6.31
6% 6%
54%
5.42 5.42
9% 9%
46%
- Selling and Administrative Expenses 27 27
4% 4%
230%
- Research and Development Expense 22 22
3% 3%
187%
-43 -43
5% 5%
-362%
- Depreciation and Amortization 0.98 0.98
8% 8%
8%
EBIT (Operating Income) EBIT -43 -43
5% 5%
-371%
Net Profit -40 -40
4% 4%
-343%

In millions USD.

Don't miss a Thing! We will send you all news about Hyperfine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hyperfine Stock News

Neutral
Business Wire
about 22 hours ago
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.
Neutral
Business Wire
10 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.
Neutral
Business Wire
15 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced FDA clearance of its next-generation software. This tenth-generation release delivers a substantial leap in image quality for ultra-low-fie...
More Hyperfine News

Company Profile

Hyperfine, Inc. is a medical device development company, which is engaged in the development of, MRI solutions and non-invasive neural monitoring technology. The company was founded by Jonathan M. Rothberg on February 25, 2014 and is headquartered in Guilford, CT.

Head office United States
CEO Maria Sainz
Employees 131
Founded 2014
Website hyperfine.io

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today